Core Viewpoint - Neuralink, a brain-computer interface company owned by Elon Musk, plans to begin large-scale production of brain-computer interface devices in 2026 and is completing a new round of financing. The company is exploring potential business collaborations with other firms in the industry [1]. Group 1: Company Collaboration - Meihua Medical (301363.SZ) confirmed on an investor interaction platform that it is a strategic partner and core supplier for artificial cochlear implants, which are a significant application direction for brain-computer interfaces [1]. - The company has nearly 15 years of deep collaboration with clients in the research and development and production transformation of artificial cochlear components [1]. - The invasive brain-computer interface products share key technological aspects with artificial cochlear implants, including material selection, biocompatibility requirements, production processes, and quality system control [1]. Group 2: Business Development - The company is actively engaging in process exploration and technical cooperation with innovative brain-computer interface clients to assist them in efficiently commercializing their products from laboratory research to mass production [1]. - Currently, the revenue generated from the company's brain-computer interface business is relatively small [1].
美好医疗：目前，公司脑机接口业务产生的收入规模较小